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Studies in cultured human fibroblasts have defined a  metabolic pathway by 
which these cells are able to take up and utilize  cholesterol contained in low 
density  lipoprotein  (LDL), 1 the  major  cholesterol-carrYing  protein  in  human 
plasma (reviewed in references 1 and 2). The rate-controlling  step in this LDL 
pathway involves the binding of the lipoprotein to a  high  affinity cell surface 
receptor  (3-5).  The  bound  LDL is then  internalized  by a  process resembling 
adsorptive endocytosis and the lipoprotein is delivered to the lysosomes of the 
cell where its protein and cholesteryl ester components are hydrolyzed (4, 6-8). 
The  liberated  unesterified  cholesterol  then  enters  the  nonlysosomal  cellular 
compartment where it is utilized by the cell for membrane synthesis and where 
it exerts three regulatory actions:  (a) it suppresses 3-hydroxy-3-methylglutaryl 
coenzyme A  reductase  (HMG CoA reductase),  the rate-controlling  enzyme in 
cholesterol biosynthesis, causing a reduction in the rate of endogenous synthesis 
of cholesterol (9); (b) it activates an acyl CoA:cholesterol acyltransferase that re- 
esterifies a portion of the lipoprotein-derived cholesterol, apparently to facilitate 
cholesterol storage (10,  11); and (c) it suppresses the synthesis of LDL receptor 
molecules themselves, thus limiting  LDL uptake and preventing an overaccu- 
mulation of cholesterol by the cell (12). 
The critical importance of the initial component of this pathway, namely the 
cell surface LDL receptor,  is emphasized by the finding that  fibroblasts from 
patients with the receptor-negative form of homozygous familial hypercholester- 
olemia  (FH), which lack functional  LDL receptors,  are unable to take up the 
lipoprotein with high affinity (3-5, 13-16). As a result, these mutant cells are not 
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able to use LDL cholesterol for membrane synthesis, nor do they show suppres- 
sion of HMG CoA reductase activity or stimulation of cholesterol esterification 
in the presence of LDL (reviewed in references 1 and 2). 
Recently,  Kayden  et  al.  have  reported  that  cultured  human  lymphocytes 
appear to respond to LDL in a manner similar to that of fibroblasts (17).  Using 
long-term established lymphoid cell lines from normal  human  subjects, these 
investigators demonstrated that human LDL, but not high density lipoprotein 
(HDL), caused a suppression of HMG CoA reductase activity and stimulation of 
cholesterol esterification.  These effects occurred at LDL concentrations similar 
to those at which LDL binds to its receptor in fibroblasts. As further evidence for 
the involvement of the LDL receptor in lymphocytes, these investigators found 
that lymphocytes from homozygotes with FH failed to show suppression of HMG 
CoA  reductase  activity  or  stimulation  of cholesteryl  ester  formation  when 
incubated with LDL (17). 
The present  studies  were designed to determine  whether  cultured  lympho- 
cytes do in fact possess LDL receptors and whether these receptors are absent in 
lymphocytes from a homozygote with FH. In order to answer these questions, we 
have  developed an  assay for  125I-LDL binding  that  can be applied to cells  in 
suspension such as lymphocytes. The results indicate that normal lymphocytes 
possess LDL receptors and  that  such receptors are  absent  in the homozygote 
lymphocytes. 
Materials  and  Methods 
Materials.  [~25I]sodium  (carrier  free  in  0.05  N  NaOH)  was  purchased  from  Schwarz/Mann 
Div.,  Becton,  Dickinson  &  Co.,  Orangeburg,  N.  Y.  [3H(G)]coneanavalin A  (60  Ci/mmol)  was 
obtained from New  England Nuclear,  Boston,  Mass.  [1,2-3H]cholesterol  (43 Ci/mmol) was pur- 
chased from Amersham/Searle Corp.,  Arlington Heights, Ill. RPMI 1640 medium (catalogue no. 
187G),  L-glutamine  (100x),  and  Dulbecco's phosphate-buffered saline  (catalogue  no.  419)  were 
purchased from Grand Island Biological Co., Grand Island, N. Y. Fetal calf serum was purchased 
from Flow Laboratories, Inc., Rockville, Md. Bovine serum albumin (once crystallized, catalogue 
no. A 4378) was purchased from Sigma Chemical Co., St. Louis, Mo. Polyethylene microfuge tubes 
were  obtained from  Beckman Instruments,  Inc.,  Fullerton,  Calif.  Thin-layer chromatographic 
materials and reagents for assays were obtained from sources as previously reported (9,  18). 
Cells.  Normal and FH homozygote lymphoid cell lines were established in culture by Kayden 
et  al.  (17)  using a  modification of the  method described by Beratis and  Hirschhorn  (19).  The 
homozygote lymphoid line was derived from patient O.  C.  (17).  Biochemical studies of cultured 
skin fibroblasts from O.  C.  indicate that she has the receptor-negative form of homozygous FH 
(13).  The lymphoid lines were maintained in a  humidified incubator (5% CO2) at 37°C in 250-rnl 
flasks containing RPMI 1640 medium supplemented with penicillin (100 U/ml), streptomycin (100 
/~g/ml), 1% glutamine, and 20% (vol/vol) fetal calf serum. Fresh growth medium was added every 
other day so as to maintain the lymphocytes at a  concentration of about 1.5  ×  10  e cells/ml. No 
differences were detected in either the morphological characteristics or growth rates of the normal 
and homozygote cell strains. For experimental studies, cells from stock cultures were collected by 
centrifugation (1,700 rpm, 5 rain, 24°C),  washed twice with 8 ml of Dulbecco's phosphate-buffered 
Saline, and resuspended in either buffer A  or growth medium as indicated below.  Cell viability 
was determined by exclusion of erythrosin B.  Under all conditions, at least 90-95% of the cells 
were viable. 
Lipoproteins.  Human LDL (density 1.019-1.063 g/ml), human HDL (density 1.085-1.215 g/ml), 
and human lipoprotein-deficient serum  (LPDS)  (density  >  1.215  g/ml) were obtained from the 
plasma  of healthy  subjects  and  prepared  by  differential  ultracentrifugation  (9).  Lipoprotein- 
deficient fetal calf serum was prepared as previously described (18). The concentration of LDL and 
HDL is expressed in terms of their protein content. The mass ratio of total cholesterol to protein in 446  LIPOPROTEIN  METABOLISM  IN  CULTURED  LYMPHOCYTES 
LDL and HDL was 1.6:1  and 1:3, respectively.126I-LDL was prepared as previously described (3). 
[SH]cholesteryl linoleate was prepared by the method of Goodman (20), isolated and purified by 
silicic  acid:celite  column  chromatography  (21)  and  stored  at  room  temperature  in  benzene. 
[SH]cholesteryl linoleate-labeled LDL was prepared as previously described (6). 
Surface Binding of 126I-LDL by Intact Lymphocytes at 4°C.  Cells were seeded at a concentration 
of about 50 x  106 cells/250 ml flask in 50 ral of growth medium containing 10% calf LPDS (1  x  106 
cells/ml). After incubation for 36 h at 37°C, the cells from two flasks were harvested by centrifuga- 
tion (1,700 rpm,  10 rain, 4°C),  washed once in 10 ml of buffer A  (Dulbecco's phosphate-buffered 
saline containing 50 ~aM CaCI2 and 20 mg/ml bovine serum albumin), and resuspended in ice-cold 
buffer A at a final concentration of about 65 x  106 cells/ml. The binding assays were carried out in 
400-~1 polyethylene microfuge tubes that had been precoated with 1% Siliclad (Clay-Adams, Inc., 
Parsippany, N. J.). Just before its use, the ~"I-LDL was diluted to the appropriate concentration 
with buffer A and passed through a Millipore filter (0.45 ~ra). Incubations were conducted in a 4°C 
cold room as described in the figure legends, and the total amount of 126I-LDL bound to the cells 
was determined using the following standard washing procedure: At the completion of the binding 
assay, each tube was centrifuged in a Beckman Microfuge Model 152 (12,000 rpm, 2 rain, 4°C). The 
supernate was discarded,  and the top of the cell pellet was rinsed with 300  ftl of buffer A  and 
recentrifuged immediately (12,000 rpm, 1 rain, 4°C). The cell pellet was then suspended in 75 ~1 of 
buffer A,  a  65-~tl  aliquot of this suspension was  layered onto 300  /~1 of 100%  fetal calf serum 
contained within a  siliconized 400 ~1 microfuge tube, and each tube was then centrifuged (12,000 
rpm, 5 rain, 4°C)  in a  modification of the method described by Kulczycki et al.  (22).  The entire 
supernate was removed, and the bottom of the tube containing the cell pellet was cut off with a 
razor blade and placed in a  plastic tube for radioactivity determination in a  well-type gamma 
counter. After counting, the tip of the raicrofuge tube containing the cell pellet was transferred to 
a  glass  tube containing 0.5  ml  of 0.1  N  NaOH  and the cell pellet  was  allowed  to dissolve by 
overnight incubation at 37°C,  after which an aliquot was removed for protein determination. 
Cellular  Accumulation  and  Proteolytic  Degradation  of  ~26I-LDL by  Intact  Lymphocytes  at 
3 7°C.  Cells were seeded at a  concentration of about 2  x  108 cells/30 ml flask in 2 ml of growth 
medium containing 10% human LPDS (1 x  106 cells/ml). After the cells were incubated for 36 h at 
37°C,  t2~I-LDL was added to each flask as indicated and incubations were continued at 37°C.  After 
the indicated interval, the cells and medium were separated by centrifugation (1,700 rpra, 5 rain, 
4°C). The medium was then treated with TCA to a final concentration of 10% (vol/vol), the soluble 
fraction was treated with hydrogen peroxide and then extracted with chloroform to remove free 
iodine  (23),  and an aliquot of the aqueous phase was counted to determine the amount of ~25I- 
labeled acid-soluble material formed by the cells and released to the medium (4).  A blank value 
due to the presence of small amounts of acid-soluble material (<0.01% of total added radioactivity) 
in the ~2SI-LDL preparation was routinely determined at the appropriate LDL concentration by 
incubation in growth medium containing no cells (4).  To determine the total cellular content of 
~zSI-LDL (i.e., the ~25I-LDL contained both at the receptor site on the cell surface and within the 
cell), after removal of the incubation medium the cell pellet from each flask was washed with 5 ral 
of buffer B (Dulbecco's phosphate-buffered saline containing 5 mg/ml bovine serum albumin) and 
collected by centrifugation (1,700 rpm, 5 min, 4°C).  After this procedure was repeated three times, 
each cell pellet was resnspended in  100  gl of buffer B.  A  75-gl aliquot of this suspension was 
layered onto 300/xl of 100% fetal calf serum contained in a siliconized 400/xl raicrofuge tube and 
each tube was then centrifuged (12,000 rpm, 5 min, 4°C).  The entire supernate was removed, and 
the bottom of the tube containing the cell pellet was cut off with a razor blade, counted directly for 
radioactivity, and then used for determination of protein content after the pellet was dissolved in 
NaOH as described above. 
Hydrolysis of  [~H]Cholesteryl Linoleate-Labeled LDL by Intact Lymphocytes.  Cells were seeded 
and incubated in the same manner as  described for  measurement of  126I-LDL protein accumulation 
and degradation.  After incubation for 36 h at 37°C, the cells were exposed to [SH]cholesteryl 
linoleate-labeled LDL  as indicated and incubations were continued at 37°C. After the indicated 
time interval, the cells  were collected by centrifugation  (1,700 rpra, 5 min, 4°C). The cells  were 
washed exactly as described above for  determination of  the cellular  accumulation of  ~2SI-LDL. The 
final  cell  pellet,  after  centrifugation through 100% fetal  calf  serum, was resuspended in 200 ~l of 
water. An aliquot (10 pl) was removed for determination of protein content and the remaining 
suspension was extracted with 20 volumes of chloroform:methanol  (2:1)  after  the addition of an Y.  K.  HO,  M.  S.  BROWN,  H.  J.  KAYDEN,  AND  J.  L.  GOLDSTEIN  447 
internal  standard  containing [14C]cholesterol  (30/~g,  500  cpm) and unlabeled cholesteryl  linoleate 
(30  pg).  The free  and esterified  [3H]cholesterols  were separated by thin-layer  chromatography as 
previously  described (6). 
Measurement of  Cellular Content of  Free and Esterified  Cholesterol.  Lymphocytes in  suspen- 
sion  culture  were  incubated with  LDL in  growth  medium supplemented  with  20%  calfLPDS. After 
the indicated  interval  the cells  and medium were separated by centrifugation  (1,700  rpm, 5 rain, 
4°C).  The  cells  were washed four  times with  5 ml of  ice-cold  buffer  C (50  mM  Tris-chloride,  pH 7.4; 
150  mM  NaCl; and 2 mg/ml of  bovine  serum albumin), after  which each  cell  pellet  was suspended 
in  500/zl  of  buffer  C and  was  layered  onto  700 ftl  of  100%  calf  LPDS contained in  a  siliconized  1.5  ml 
microfuge tube. The tube was subjected to centrifugation (11,000  rpm, 5 rain,  4°C)  and the 
resulting  cell  pellet  was washed  once  more  in  5  ml  of  buffer  containing  50  mM  Tris-chloride,  pH 7.4 
and 150  mM  NaCl. The  final  cell  pellet  was resuspended  in  200 pl  of  water. An aliquot  (10  ~l)  was 
removed for  determination  of  protein  content  and  the  remaining  suspension was extracted  with  20 
volumes of  chloroform:methanol (2:1)  for  steroid  measurement. The free  and  esterified  cholesterol 
fractions  were separated on  silicic  acid:celite  columns, and  the cholesterol  content  in  each  fraction 
was measured by gas liquid  chromatography as previously  described  for  fibroblasts  (21). 
Other.  The  protein  concentration  of  extracts  and  intact  cells  was  determined  by  a modification 
of  the method of  Lowry et  al. (24),  using bovine  serum albumin as a standard. In all  figures  and 
tables,  each value represents  the average of  duplicate  assays or incubations. 
Results 
When normal lymphocytes were incubated for 36 h  in the absence of lipopro- 
teins and then exposed to 125I-LDL (10 ~g protein/ml) at 4°C, there was a rapid 
binding of the lipoprotein to the cells with equilibrium achieved by 30 min (Fig. 
1 A). In the presence of a 25-fold excess of unlabeled LDL, the binding of 12SI-LDL 
was reduced by 90%, indicating that the unlabeled LDL was competing with the 
'25I-LDL for a limited number of binding sites. In the same experiment, the total 
binding  of 125I-LDL to lymphocytes derived from an  FH homozygote was less 
than 10% of the total binding observed in the normal cells (Fig. 1 B). Moreover, 
there was no evidence of competition by excess unlabeled LDL, indicating that 
the homozygote cells were completely lacking in saturable LDL-binding sites. 
Further evidence for this deficiency in LDL binding in the homozygote cells 
was obtained from studies of the saturation kinetics of ~2SI-LDL binding at 4°C 
(Fig. 2). In the homozygote cells, as the concentration of ~25I-LDL was increased 
the amount of cell-bound ~25I-LDL increased in a  linear fashion indicating the 
absence  of high  affinity  binding  sites.  In  contrast,  the  normal  lymphocytes 
exhibited  a  two  component  binding  curve,  a  high  affinity  component  that 
appeared to reach saturation at about 25 ~g protein/ml and a linear, apparently 
nonsaturable  component  that  paralleled  the  nonsaturable  component  in  the 
homozygote cells.  Assuming that  the protein  component of LDL accounts for 
20%  of the  total  molecular  weight  of the  LDL  particle  (-3  ×  l0  s)  (25),  we 
calculated that  at 4°C  about 1,800-3,600 particles of LDL were bound to each 
normal  cell  at  saturation.  The  nature  and  significance  of the  nonsaturable 
linear component of the ~zSI-LDL-binding  curve in both the normal and homozy- 
gote cells is  not yet clear,  but it is possible that  this  component reflects the 
trapping of droplets of extracellular fluid that are not completely removed by the 
wash procedure. Although unlabeled LDL competed with ~2SI-LDL for binding to 
the surface receptor site in normal cells, HDL did not compete effectively (Fig. 
3). 
As previously described for the LDL receptor in human fibroblasts (4), binding 448  LIPOPROTEIN  METABOLISM  IN  CULTURED  LYMPHOCYTES 
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Fro. i.  Time-course  of  ~2SI-LDL  binding  at  4°C in  normal (A) (@, O) and FH homozygote 
(B) (&, /x)  lymphocytes. After incubation for  36 h at 37°C in medium containing 10% calf 
LPDS, cells  were harvested, washed, and resuspended in ice-cold  buffer  A  at a final 
concentration of  about 65 x 106 cells/ml.  Each binding assay was conducted in 100 ~l of 
buffer  A containing 4 x 106  intact  cells  (320-450/~g  of  total  cell  protein)  and 10 ~g protein/ 
ml of  ~2~I-LDL  (252  cpm/ng) in  the presence (O, A) and  absence  (@, A)  of  250 pg  protein/ml 
of  native  LDL. After  incubation at  4°C for  the indicated  time,  the total  amount of  'sSI-LDL 
bound to the cells  was determined as described  in  the Materials and Methods. 
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Fzo. 2.  '251-LDL  binding at 4°C in normal (@) and homozygote (b) lymphocytes as a 
function  of  '2~I-LDL  concentration.  After  incubation for  36  h at  37°C in  medium containing 
10%  calfLPDS, cells  were  harvested,  washed, and  resuspended  in  ice-cold  buffer  A at  a  final 
concentration of  about 65 × 106 cells/ml,  Each binding assay was conducted in 100 /~l of 
buffer  A containing 5 x 10  s  intact  cells  (500-600  ~g of  total  cell  protein)  and the indicated 
concentration  of  ~2SI-LDL  (exp.  A, 193  cpm/ng;  and  exp.  B, 164  cpm/ng). After  incubation at 
4°C for  15  min, the total  amount of  ~SI-LDL  bound  to  the  cells  was determined  as  described 
in the Materials and Methods. 
of 125I-LDL to the lymphocyte receptor required Ca ++. In the presence of 100/~M 
EDTA and no added Ca ++, high affinity 125I-LDL binding was not detectable, but 
this binding was restored completely by the addition of 150/~M Ca ++ (data not 
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FIG.  3.  Effect of serum lipoprotein fractions on ~2~I-LDL binding to normal lymphocytes at 
4°C.  After incubation for  36  h  at  37°C  in  medium  containing 10%  calf LPDS,  normal 
lymphocytes were harvested,  washed,  and  resuspended in  ice-cold buffer A  at  a  final 
concentration of about 65  x  106 cells/ml. Each binding assay was conducted in 100/~1  of 
buffer A  containing 4.5  x  106 intact cells (400-490  /zg of total cell protein); the indicated 
concentration of either unlabeled HDL (A) or unlabeled LDL (@); and 10/~g protein/ml of 
~25I-LDL (123 cpm/ng). The cells were incubated at 4°C for 30  rain, after which the total 
amount of 125I-LDL bound to the cells was determined as described in the Materials and 
Methods. 
In contrast to their  lack of LDL-binding sites,  the homozygote lymphocytes 
bound the same amount of [3H]concanavalin A as did normal lymphocytes at 4°C 
(Table I).  In  both  the  normal  and  homozygote cells,  the  [3H]concanavalin  A 
binding was inhibited by a-methyl-D-mannopyranoside. 
When normal lymphocytes were incubated with 125I-LDL at 37°C, the cellular 
content  of lipoprotein  reached  a  steady state  within  1 h  (Fig.  4 A).  As  with 
cultured  fibroblasts,  this  constant  cellular  content  appeared  to result  from  a 
dynamic equilibrium in which the rate of uptake of the lipoprotein was equal to 
its rate  of degradation  (4).  Thus,  during  this  steady state period,  ~25I-labeled 
acid-soluble  degradative  products  continued  to  be  released  into  the  culture 
medium at a rate that was linear with time for at least 6 h  (Fig. 4 A). That this 
uptake and  degradation  required binding  of LDL to the high  affinity surface 
receptor  was indicated  by the  observation that  the homozygote lymphocytes, 
which lacked cell surface binding, did not take up or degrade the lipoprotein at a 
detectable rate when it was present at 10 pg protein/ml  (Fig. 4 B). 
Further  evidence for the participation  of the surface receptor in the uptake 
process came from studies of the saturation kinetics for the uptake and degrada- 
tion of ~2SI-LDL at 37°C  (Fig.  5).  In the normal  cells the steady state cellular 
content of ~25I-LDL rose sharply as the concentration of ~2~I-LDL was increased, 
until  at  25-50  ~g/ml  when  saturation  appeared  to  be  reached.  Above  this 
concentration,  the cellular content of 125I-LDL rose in a  gradual linear fashion 
with increasing  concentration  of 125I-LDL in  the medium.  In the homozygote 
cells the initial high affinity component of the saturation curve was absent, but 
the  gradual  linear  slope  was  present.  As  with  the  apparently  nonsaturable 
component of the 4°C binding curve, the nature of the linear component of the 
uptake curve at 37°C is not known.  Examination  of the rate of degradation  of 
125I-LDL as a  function of ~2~I-LDL concentration  indicated that only the initial 
high affinity component of the uptake curve provided substrate for the degrada- 
tive process. Thus, in the normal cells degradation reached a maximum rate at 450  LIPOPROTEIN  METABOLISM  IN  CULTURED  LYMPHOCYTES 
TABLE  I 
Binding of [aH]Concanavalin A  at 4°C in Normal and 
Homozygote Lymphocytes 
Cell strain 
Concentration  [3H]concanavalin A 
of  bound to cells 
[3H]concanavalin 
A in medium  -  a-MMP  +  a-MMP 
Normal 
gg/ml  ng/mg protein 
1  22  3 
5  89  6 
25  443  30 
Familial  hypercho-  1  15  3 
lesterolemia  hom-  5  77  4 
ozygote  25  406  15 
Lymphocytes were cultured,  harvested, washed, and resuspended in 
cold buffer A exactly as described for the '25I-LDL-binding studies. Each 
binding assay contained the following in a final vol of 100/xl of buffer A: 
4 x  108 intact cells (360-480/~g of total cell prQtein), [~H]concanavalin A 
(44  cpm/ng)  at  the  indicated concentration, and  0.2  M  a-methyl-D- 
mannopyranoside (a-MMP) as indicated. After incubation at 4°C for 30 
rain,  the total amount of [3H]concanavalin A  bound to the cells was 
determined as  described in  the  Materials  and  Methods for  '~SI-LDL 
binding  except  that  the  final  pellet  obtained  after  centrifugation 
through fetal calf serum was dissolved in 1 ml of 10% Triton X-100 and 
counted in Triton-toluene scintillation solution in a liquid scintillation 
counter. 
50 ~xg protein/ml of x~SI-LDL, a concentration at which the uptake process was 
saturated.  Moreover, in the homozygote cells no degradation of '25I-LDL was 
detectable at concentrations of LDL up to 200/xg protein/ml. 
Just as the normal lymphocytes hydrolyzed the protein component of LDL, so 
too did they hydrolyze the  cholesterol  ester  component,  as  indicated by the 
hydrolysis of [3H]cholesteryl linoleate-labeled LDL (Fig. 6).  Again, the rate of 
such hydrolysis was limited by the rate of uptake of the lipoprotein, as indicated 
by the observation that this rate reached a maximum at an LDL concentration 
of about  50  /xg  protein/ml.  Moreover,  in  the  homozygote cells  the  rate  of 
hydrolysis paralleled the  rate  of the  nonsaturable uptake  process.  That the 
hydrolysis of the protein and cholesteryl esters of LDL occurred in lysosomes of 
lymphocytes, as previously shown for fibroblasts (6-8),  was indicated by a study 
of the  optimum pH  for such hydrolysis in  cell-free extracts of lymphocytes. 
Maximal rates of hydrolysis for both the protein and cholesteryl ester compo- 
nents of LDL occurred at about pH 4 (data not shown). 
Table II shows that, as in human fibroblasts (21), the net result of  the addition 
of LDL to normal lymphocytes was a  sixfold accumulation of esterified choles- 
terol,  whereas  in  the  homozygote cells  no  such  accumulation of esterified 
cholesterol was detected.  In both the normal and homozygote cells,  the free 
cholesterol content was somewhat higher after growth in the presence of LDL. 
The mechanism for the slight increase in free cholesterol in the homozygote cells Y.  K.  HO,  M,  S.  BROWN,  H.  J.  KAYDEN,  AND  J.  L.  GOLDSTEIN  451 
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FIG.  4.  Time-course  of metabolism  of ~2~I-LDL in  normal  (A)  and  FH  homozygote  (B) 
lymphocytes at 37°C.  Cells were seeded at a concentration of 2 x  106 cells/30 ml flask in 2 ml 
of growth  medium  containing 10%  human LPDS  (I  ×  10  ~ cells/ml).  After the cells had 
incubated for 36 h at 37°C (zero time), 10 ~g protein/ml of ~SI-LDL (123 cpm/ng) was added 
to each flask and the incubations were continued at 37°C. At the indicated time, the medium 
and cells from each flask were separated by centrifugation, after which the content of ]25I- 
labeled acid-soluble material in the medium (A, A) and the cellular content of ~25I-LDL (@, 
O)  were determined as described in the Materials and Methods.  The average content of 
cellular protein was 410 /~g/flask for the normal cells and 390/~g/flask for the homozygote 
cells.  Closed  symbols  (A,  @)  refer  to  normal  cells;  open  symbols  (A,  ©)  refer  to  the 
homozygote cells. 
is not known, but it presumably occurs through a mechanism not involving the 
LDL receptor. 
Discussion 
The studies reported in this paper, coupled with the previous observations of 
Kayden et al.  (17), indicate that long-term established human lymphoid cells 
are able to utilize the LDL pathway to obtain cholesterol and regulate their 
cellular sterol  homeostasis.  That  the  cell  surface LDL  receptor in  cultured 
lymphocytes  is the same as that previously described for human fibroblasts (1-5, 
15) is suggested by the observation that this receptor is absent in both lympho- 
cytes and fibroblasts obtained from the same patient with the homozygous form 
of FH. 
Because of the small number of high affinity LDL receptors in normal cells, 
demonstration of their absence in the homozygote lymphocytes necessitated the 
development of a  binding assay in  which a  high proportion of the  observed 
binding of 125I-LDL represented binding to  the  LDL  receptor.  Initially,  this 
proved difficult because ~I-LDL tended to become trapped in the cell pellet in 
an amount that was proportional to its concentration in the incubation medium. 
In  a  large  number of preliminary experiments in  which lymphocytes were 
washed by repeated resuspension and centrifugation in a variety of buffers, we 
could not obtain reproducible results.  Moreover, when these techniques were 
used the amount of specific or displaceable 125I-LDL binding was always small in 452  LIPOPROTEIN  METABOLISM  IN  CULTURED  LYMPHOCYTES 
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Fro.  5.  Cellular content of 125I-LDL in the steady state  (A)  and  its rate of proteolytic 
degradation (B) at 37°C as a function of x2SI-LDL concentration in normal (@) and homozy- 
gote (A) lymphocytes. Cells were seeded at a concentration of 2 x  10  e cells/30 ml flask in 2 
ml of growth medium containing 10% human LPDS (1  ×  !06 cells/ml). After the cells had 
incubated for 36 h at 37°C, the indicated concentration of ~2SI-LDL (36 cpm/ng) was added to 
each flask.  The  incubations were continued at  37°C for a  further 5 h,  after which the 
medium and cells from each flask were separated by centrifugation, and the content of '25I- 
labeled acid-soluble material in the medium (B)  and the cellular content of '=SI-LDL (A) 
were determined as described in the Materials and Methods. The average content of cellular 
protein was 290 ~g/flask for the normal cells and 390 ~g/flask for the homozygote cells. 
comparison  with the  nondisplaceable  (i.e.,  nonsaturable)  binding  component. 
However, when we adopted a modification of the procedure used by Kulczycki et 
al. in which the washed lymphocytes are sedimented through 100% serum (22), 
we were able to reduce the nonspecific blank value to low proportions. The '25I- 
LDL-binding  assay  was  also  improved  considerably  when  the  stock  125I-LDL 
solution was diluted in the presence of high concentrations of albumin (20 mg/ 
ml)  and  passed through  a  Millipore  filter just before use.  This  procedure ap- 
peared to eliminate aggregates of 125I-LDL that had a stubborn tendency to spin 
down with cells at 4°C. 
That the 125I-LDL-binding assay as finally developed did in fact measure the 
binding of ~25I-LDL to the physiologically important LDL receptor was indicated 
by several findings:  (a) the LDL receptor was saturated at an LDL concentra- 
tion of 25-50 ~g protein/ml,  the concentration range at which LDL maximally 
suppressed HMG CoA reductase activity and maximally stimulated cholesterol 
esterification in lymphocytes (17); (b) the LDL receptor displayed a  specificity 
toward  LDL  in  comparison  with  HDL  and  this  correlated  with  the  greater 
ability of LDL to suppress HMG CoA reductase and activate cholesterol esterifi- 
cation (17); and (c) the LDL receptor was absent in lymphocytes from a homozy- 
gote with FH in whom previous studies have shown an absence of LDL-mediated 
effects on cholesterol synthesis and cholesteryl ester formation (17). 
As with human  fibroblasts, binding  of LDL to its receptor was followed by 
internalization  and  degradation  of the lipoprotein.  This  was indicated by the 
fact that normal lymphocytes, which bound ~25I-LDL at the high affinity recep- 
tor site, also hydrolyzed both the protein and cholesteryl ester components by a 
process that achieved a maximal rate at the concentration of LDL that saturated Y.  K.  HO,  M.  S.  BROWN,  H.  J.  KAYDEN,  AND  J.  L.  GOLDSTEIN  453 
500 
c~  400 
~  300 
,,,  200 
~  IO0 
132 
0 
Z  0 
0 
/ 
r 
,~'&'F  l  l  I  I  I 
20  40  60  80  100  120 
LDL (pg protein/ml} 
FIG.  6.  Effect of LDL concentration on the rate of hydrolysis of [3H]cholesteryl linoleate- 
labeled LDL by normal (O) and homozygote (A) lymphocytes at 37°C. Cells were seeded at a 
concentration of 2 ×  106 cells/30 ml flask in 2 ml of growth medium containing 10% human 
LPDS  (1  ×  10  e cells/ml). After the cells had incubated for 36  h  at  37°C,  the  indicated 
concentration of  [3H]cholesteryl linoleate-labeled LDL  (18,400  cpm/nmol of cholesteryl 
linoleate) was added to each flask. The incubations were continued at 37°C for 5 h, after 
which the medium and cells from each flask were separated by centrifugation and the 
cellular content of free [3H]cholesterol was determined as described in the Materials and 
Methods. The average content of cellular protein was 258 ~g/flask for the normal cells and 
315 ~g/flask for homozygote cells. 
TABLE  II 
Cholesterol  Content of Normal and Familial 
Hypercholesterolemia  Homozygote  Lymphocytes Incubated with 
Varying Concentrations  of LDL 
Cellular cholesterol content (~g sterol/mg pro- 
tein) 
Concentration of 
LDL in medium  Normal cells  FH homozygote cells 
Free  Esterified  Free  Esterified 
pg protein/ml 
0  23  1.8  24  1.4 
12.5  35  3.4  36  ~  1.8 
25  35  9.4  34  1.8 
150  35  11.5  30  1.6 
Cells were seeded at a concentration of  3 × 106 cells/30 ml flask in 4 ml of 
growth medium containing 20% calfLPDS (7.5 ×  105 cells/ml). After the 
cells had incubated for 36 h at 37°C, the indicated concentration of LDL 
was added to each flask. The incubations were continued for 24 h, after 
which the cellular content of free and esterified cholesterol was deter- 
mined as described in the Materials and Methods. 
the LDL receptor. Moreover, the homozygote cells,  which lacked the receptor, 
did not show high affinity hydrolysis of LDL protein and cholesteryl esters. 
Summary 
Long-term established human lymphoid cells were shown to possess  high 
affinity cell  surface receptors for  low  density lipoprotein  (LDL),  the  major 454  LIPOPROTEIN  METABOLISM  IN  CULTURED  LYMPHOCYTES 
cholesterol-carrying protein in human plasma.  Binding of LDL to these recep- 
tors  was  followed  by  internalization  of the  lipoprotein  and  hydrolysis  of its 
protein and cholesteryl ester components. Cultured lymphocytes from a patient 
with the homozygous form of familial hypercholesterolemia lacked cell surface 
LDL receptors and therefore failed to take up and degrade the lipoprotein with 
high  affinity.  Cultured  human  lymphocytes  should  prove  useful  for  further 
studies of: (a) the relation between cholesterol metabolism and cellular function 
and  (b)  the  mechanism  by  which  LDL  binding  at  the  cell  surface  leads  to 
internalization  of the lipoprotein. 
Jean Helgeson,  Gloria  Y.  Brunschede,  Mary Sobhani,  and Jerry R.  Faust provided  excellent 
technical  assistance. 
Received for publication 12 April 1976. 
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